Search Results

The Stryker PainPump delivers controlled amounts of medication directly to the intraoperative site for pain management and/or antibiotic administration. The pump infuses the medication at an hourly flow rate. Medications are infused through intramuscular or subcutaneous routes,

The Stryker PainPump is also intended for controlled delivery of local anesthetics in close proximity to nerves for postoperative regional anesthesia and pain management. Routes of administration may be intraoperative, perineural, or percutaneous.

The Stryker PainPump delivers controlled amounts of medication directly to the intraoperative site for pain management and/or antibiotic administration. The pump infuses the medication at an hourly flow rate. Medications are infused through intramuscular or subcutaneous routes.

The Stryker PainPump is also intended for controlled delivery of local anesthetics in close proximity to nerves for postoperative regional anesthesia and pain management. Routes of administration may be intraoperative, perineural, or percutaneous.

The Stryker PainPump kit models are available in fill volumes from 120 to 270 cc and flow rates from 0.60 - 8.32 cc/hr. Each pump kit consists of a pump, introducer needle(s), infusion set(s), syringe(s), dressing(s), attachment strap, and accessories.

This document is a 510(k) premarket notification for the Stryker PainPump, which is a medical device for infusing medication. The document asserts the device's substantial equivalence to previously marketed devices rather than presenting a study to prove its performance against specific acceptance criteria.

Therefore, most of the requested information cannot be extracted directly from the provided text because it describes a regulatory submission, not a performance study.

Here's a breakdown of what can and cannot be answered based on the provided text:

Acceptance Criteria and Device Performance Study Information

Summary of the Document's Approach:

The provided text is a 510(k) Premarket Notification, which is a regulatory pathway to demonstrate that a new device is "substantially equivalent" to a legally marketed predicate device. This process does not typically involve conducting new large-scale clinical trials or detailed performance studies against specific acceptance criteria in the way a PMA (Premarket Approval) might.

Instead, the submission for the Stryker PainPump relies on:

• Comparison of Intended Use: The Stryker PainPump's intended use (delivering medication for pain management and/or antibiotic administration) is equivalent to existing infusion pump systems.
• Comparison of Technological Characteristics/Design: The document indirectly implies structural and functional similarity by stating it "does not raise any new safety and efficacy concerns when compared to similar devices already legally marketed."
• Comparison to Predicate Devices: The document explicitly names competitors' devices (Stryker, I-Flow Corporation, Sgarlato for pumps; Styker, I-Flow, and Sims Portex for catheters) as benchmarks for equivalence in intended use, safety, and effectiveness.

Therefore, the "study" proving the device meets criteria is effectively the 510(k) submission itself, where "meeting criteria" means demonstrating substantial equivalence to already approved predicate devices. The acceptance criteria in this context are those required by the FDA for 510(k) clearance, primarily proving that the device is as safe and effective as a legally marketed predicate device.

Ask a specific question about this device

PainPump2 delivers controlled amounts of medication directly to the intraoperative site for pain management and/or antibiotic administration. The pump infuses the medication at an hourly flow rate and provides the option for patient controlled bolus doses. Medications are infused through intramuscular or subcutaneous routes. PainPump2 is also intended for controlled delivery of local anesthetics in close proximity to nerves for postoperative regional anesthesia and pain management. Routes of administration may be intraoperative, perineural, or percutaneous.

The Stryker PainPump2 delivers controlled amounts of medication directly to the intraoperative site for pain management and/or antibiotic administration. The pump infuses the medication at an hourly flow rate and provides the option for patient controlled bolus doses. Medications are infused through intramuscular or subcutaneous routes. The Stryker PainPump2 is also intended for controlled delivery of local anesthetics in close proximity to nerves for postoperative regional anesthesia and pain management. Routes of administration may be intraoperative, perineural, or percutaneous. The Stryker PainPum2 is a kit that is comprised of an infusion set(s), introducer needle(s), syringe, and catheter securement accessories.

The provided document is a 510(k) premarket notification for the Stryker PainPump2, which focuses on demonstrating substantial equivalence to existing legally marketed predicate devices. This type of submission generally does not include detailed studies with specific acceptance criteria and performance metrics in the way a clinical trial for a novel device or software exhibiting AI/ML capabilities would.

Therefore, many of the requested details about acceptance criteria, study design, expert involvement, and ground truth are not present in this document. The submission relies on a comparison of intended use, safety, and effectiveness to already cleared devices rather than providing new performance data from a clinical study.

Here's a breakdown of what can and cannot be answered based on the provided text:

1. A table of acceptance criteria and the reported device performance

• Not Applicable / Not Provided: The submission does not present specific quantitative acceptance criteria or performance metrics for the Stryker PainPump2 in the way a diagnostic device or AI algorithm would. Its primary claim is substantial equivalence to predicate devices (I-Flow Corporation infusion pump systems and I-Flow/Sims Portex catheters) based on intended use, safety, and effectiveness.

2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

• Not Applicable / Not Provided: The document does not describe a "test set" in the context of performance evaluation with specific sample sizes. There's no mention of a study involving patient data to assess the device's performance. The substantial equivalence argument is based on comparing the device's design and intended use to existing, cleared devices.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

• Not Applicable / Not Provided: As there is no described test set or ground truth establishment process related to a performance study, this information is not relevant to this 510(k) submission.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

• Not Applicable / Not Provided: No test set or adjudication method is described.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

• Not Applicable / Not Provided: This question is relevant for AI/ML-powered diagnostic tools. The Stryker PainPump2 is an electromechanical ambulatory infusion pump; it does not involve human readers or AI assistance in the way a diagnostic imaging system would.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

• Not Applicable / Not Provided: This device is a physical infusion pump, not an algorithm. Therefore, no standalone algorithm performance study was conducted or is relevant.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

• Not Applicable / Not Provided: No performance study with a "ground truth" is described in the document.

8. The sample size for the training set

• Not Applicable / Not Provided: As this is an electromechanical device and not an AI/ML algorithm, there is no "training set" in the context of machine learning.

9. How the ground truth for the training set was established

• Not Applicable / Not Provided: This question is not relevant for the type of device and submission provided.

Ask a specific question about this device

PainPump2 is an electromechanical pump which delivers a controlled amount of medication to the patient for the purpose of managing pain. The pump delivers medication using one or both of the following drug delivery profiles: an hourly flow rate and a bolus PCA (patient controlled anesthetic) dosing option. Routes of administration may be intraoperative, subcutaneous, or percutaneous. Dosage rates and patient lock out times are programmed into the PainPump II unit by the physician. The PainPump II is contraindicated for infusion of blood and blood products, insulin, or life-supporting medication.

The Stryker PainPump2 is intended an electromechanical pump which delivers a controlled amount of medication to the patient for the purpose of managing pain. The pump delivers medication using one or both of the following drug delivery profiles: an hourly flow rate and a bolus PCA (patient controlled anesthetic) dosing option. Routes of administration may be intraoperative, subcutaneous or percutaneous. Dosage rates and patient lock out times are programmed into the PainPump2 unit by the physician.

This document, K030885, concerns a 510(k) premarket notification for the Stryker PainPump2. It is a submission for substantial equivalence to legally marketed predicate devices, not a study proving device performance against acceptance criteria. Therefore, most of the requested information regarding acceptance criteria and performance studies is not available within this document.

Here's a breakdown of the available information:

1. A table of acceptance criteria and the reported device performance

This document does not contain a table of acceptance criteria or reported device performance. A 510(k) submission primarily focuses on demonstrating substantial equivalence to a predicate device, rather than presenting a detailed performance study against specific acceptance criteria.

2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

Not applicable. This document does not describe a clinical study or a test set with sample sizes.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

Not applicable. This document does not describe the establishment of a ground truth by experts.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

Not applicable. This document does not describe an adjudication method for a test set.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. This document is for an electromechanical infusion pump and does not involve AI or human readers for diagnostic interpretation.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

Not applicable. This is not an AI or algorithm-based device.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

Not applicable. This document does not refer to a ground truth as it pertains to a performance study.

8. The sample size for the training set

Not applicable. There is no mention of a training set for an algorithm.

9. How the ground truth for the training set was established

Not applicable. There is no mention of a training set or ground truth for it.

Summary of what the document does provide:

• Device Name: Stryker PainPump2
• Intended Use: An electromechanical pump to deliver a controlled amount of medication for pain management, using hourly flow rates and/or bolus PCA dosing. Routes of administration can be intraoperative, subcutaneous, or percutaneous.
• Contraindications: Infusion of blood products, insulin, or life-supporting medication.
• Regulatory Basis: The submission is a 510(k) premarket notification, seeking substantial equivalence to existing infusion pump systems marketed by I-Flow Corporation.
• Conclusion: The FDA determined the device is substantially equivalent to legally marketed predicate devices, meaning it does not raise new safety and efficacy concerns compared to existing devices.

Ask a specific question about this device

Intended to provide continuous infusion of a local anesthetic directly into the intraoperative site for postoperative pain management.

Not Found

I am sorry, but the provided text only contains a 510(k) clearance letter for the Stryker PainPump and an "Indications for Use Statement."

This document does not contain information about:

• Acceptance criteria for the device's performance.
• Data from a study proving the device meets acceptance criteria.
• Sample sizes for test or training sets.
• Data provenance.
• Number or qualifications of experts.
• Adjudication methods.
• MRMC comparative effectiveness studies.
• Standalone algorithm performance studies.
• Type of ground truth used.
• How ground truth for a training set was established.

Therefore, I cannot fulfill your request to describe the acceptance criteria and the study that proves the device meets them based on the provided text.

Ask a specific question about this device

Ask a specific question about this device